Researchers adjusted for confounders like age, hypertension, cardiovascular disease, and other comorbidities. The refined results indicated GLP-1 users had a 16% lower risk of developing epilepsy ...
Amazon S3 on MSN
WHO supports weight loss drugs for tackling obesity crisis
Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...
India is already recognised as the diabetes capital of the world, with nearly 70 million people living with the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback